Genmab | GEN - Pre Tax Profit

Stock Price
1,788.50
Daily Change
37.00 2.11%
Monthly
3.68%
Yearly
53.06%
Q2 Forecast
1,668.29

Genmab reported DKK55M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Almirall EUR 30.32M 22M Dec/2025
Amarin USD -852K 7.26M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
argenx SE USD 386.05M 99.15M Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Demant DKK 1.46B 497M Jun/2025
Exelixis USD 252.69M 275K Dec/2025
Fresenius Medical Care EUR 508.46M 105.89M Dec/2025
Galapagos EUR -221.49M 117.07M Sep/2025
Genmab DKK 55M 427M Dec/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
GN Store Nord DKK 450M 332M Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Insmed USD -326.93M 41.77M Dec/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 1.29B 458.1M Sep/2025
Novartis USD 4.64B 445M Dec/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025